BridgeMD
New treatment option for Anterior Cruciate Ligament Reconstruction
Official title Anterior Femoral and Adductor Canal Nerve Blocks in Peds Knees
ClinicalTrials.gov ID: NCT06590402
What this study is testing
What is Bupivacaine, Dexamethasone in Adductor Canal Block?
Bupivacaine, Dexamethasone in Adductor Canal Block is an investigational medicine, given as an once-daily, being studied as a potential treatment for anterior cruciate ligament reconstruction.
Also referred to as Adductor Canal Block (ACB).
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The goal of this pilot clinical trial is to compare anterior femoral cutaneous nerve block (AFCN) to adductor canal block ACB) for pediatric patients undergoing either anterior cruciate ligament (ACL) or medial patellofemoral ligament (MPFL). The aims of this trial are: To measure postoperative functional outcomes in patients who received AFCNB vs.
- Phase 4: studies an already-approved treatment
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 8 to 18. Healthy volunteers may be eligible.
You may be able to join if
- 8-18 years old at the time of surgery
- Patients 40kg and above
- ACL reconstruction of MPFL reconstruction surgery with participating surgeons
You likely can't join if
- revision surgery
- bilateral surgery
- general anesthesia
- contraindications to any part of the study protocol
- relevant pre-existing neurological deficit
- chronic pain
The study team makes the final eligibility decision.
Where it's taking place
- New York, New York, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 8 years to 18 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include New York, New York, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.